Search

everythinglearnresearchcommunity

for

Search:↓

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Vitamin D receptor is crucial for starting hair growth after birth.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Astressin-B can reverse and prevent hair loss in stressed mice.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

A specific gene mutation causes congenital hair loss.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

DNA phenotyping helps predict physical traits from DNA with varying accuracy and requires careful ethical and legal handling.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Progranulin overexpression leads to shorter, thinner hair and increased cell death in mouse hair follicles.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.